Galderma Operating Margin from 2010 to 2026

GALD Stock   154.20  0.40  0.26%   
Galderma Group Operating Profit Margin yearly trend continues to be fairly stable with very little volatility. Operating Profit Margin will likely drop to 0.1 in 2026.
Check Galderma Group financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Galderma Group's main balance sheet or income statement drivers, such as Depreciation And Amortization of 265.5 M, Interest Expense of 418 M or Selling General Administrative of 495.8 M, as well as many indicators such as Price To Sales Ratio of 3.27, Dividend Yield of 0.0 or PTB Ratio of 3.29. Galderma financial statements analysis is a perfect complement when working with Galderma Group Valuation or Volatility modules.
  
This module can also supplement various Galderma Group Technical models . Check out the analysis of Galderma Group Correlation against competitors.
The evolution of Operating Margin for Galderma Group N provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Galderma Group compares to historical norms and industry peers.

Latest Galderma Group's Operating Margin Growth Pattern

Below is the plot of the Operating Profit Margin of Galderma Group N over the last few years. It is Galderma Group's Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Galderma Group's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 0.16 %10 Years Trend
Slightly volatile
   Operating Profit Margin   
       Timeline  

Galderma Operating Margin Regression Statistics

Arithmetic Mean0.10
Geometric Mean0.10
Coefficient Of Variation16.55
Mean Deviation0.01
Median0.1
Standard Deviation0.02
Sample Variance0.0003
Range0.0542
R-Value0.53
Mean Square Error0.0002
R-Squared0.28
Significance0.03
Slope0
Total Sum of Squares0

Galderma Operating Margin History

2026 0.096
2025 0.13
2024 0.15
2023 0.14
2022 0.0911

About Galderma Group Financial Statements

Galderma Group investors use historical fundamental indicators, such as Galderma Group's Operating Margin, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Galderma Group. Please read more on our technical analysis and fundamental analysis pages.
Galderma Group is entity of Switzerland. It is traded as Stock on SW exchange.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Galderma Stock Analysis

When running Galderma Group's price analysis, check to measure Galderma Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Galderma Group is operating at the current time. Most of Galderma Group's value examination focuses on studying past and present price action to predict the probability of Galderma Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Galderma Group's price. Additionally, you may evaluate how the addition of Galderma Group to your portfolios can decrease your overall portfolio volatility.